Kongressthemen 2020 marked a landmark year for mRNA-Based Therapies, and the dramatic success of mRNA-based vaccines for emergency use against COVID-19 was a triumph for a previously unproven mRNA technology. Now, the landscape of successful treatments seems limitless, and the future looks bright for mRNA therapies. With this, we are excited to announce the official release of the inaugural mRNA Based Therapeutics Summit!
Speakers: Lori Panther, Vice President, Clinical Development, Infectious Diseases, Moderna, Inc, Jacob Becraft, Chief Scientific Officer and Co-Founder, Strand Therapeutics Inc and more
